Phase 3 Renal Impairment Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Completed
Phase 3
A Randomised Double-Blind Placebo-Controlled Multicenter Study with Extension to Evaluate the Efficacy Safety and Tolerability of Canagliflozin in the Treatment of Subjects with Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment
Type 2 diabetes in patietns with moderate renal impairment.
Johnson& Johnson Pharmaceutical Research & Development, LLC240 enrolled15 locationsACTRN12610000194066
Recruiting
Phase 3
Preoperative intranenous N-Acetylcysteine for the prevention of renal failure in patients with renal impairment undergoing cardiac surgery
Renal Impairment in cardiac surgery
Prince of Wales Hospital200 enrolled1 locationACTRN12606000088549